Cargando…

Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is highly malignant. While cancers in other organs have shown clear improvements in 5‐year survival, the 5‐year survival rate of pancreatic cancer is approximately 10%. Early relapse and metastasis are not uncommon, making it difficult to achieve an acceptable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishido, Keinosuke, Hakamada, Kenichi, Kimura, Norihisa, Miura, Takuya, Wakiya, Taiichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832965/ https://www.ncbi.nlm.nih.gov/pubmed/33532676 http://dx.doi.org/10.1002/ags3.12379

Ejemplares similares

Heterogeneity of metabolic adaptive capacity affects the prognosis among pancreatic ductal adenocarcinomas
por: Kanda, Taishu, et al.
Publicado: (2022)

Development of a Biomarker-Based Scoring System Predicting Early Recurrence of Resectable Pancreatic Duct Adenocarcinoma
por: Ishido, Keinosuke, et al.
Publicado: (2021)

Perioperative Blood Transfusion as a Poor Prognostic Factor After Aggressive Surgical Resection for Hilar Cholangiocarcinoma
por: Kimura, Norihisa, et al.
Publicado: (2015)

Roles of the nervous system in pancreatic cancer
por: Wakiya, Taiichi, et al.
Publicado: (2021)

A case report of mucinous adenocarcinoma derived from intra-ampullary papillary-tubular neoplasm with a malignant course
por: Fujita, Hiroaki, et al.
Publicado: (2021)

Differential diagnoses of gallbladder tumors using CT‐based deep learning
por: Fujita, Hiroaki, et al.
Publicado: (2022)

Prediction of massive bleeding in pancreatic surgery based on preoperative patient characteristics using a decision tree
por: Wakiya, Taiichi, et al.
Publicado: (2021)

Eukaryotic initiation factor 2 signaling behind neural invasion linked with lymphatic and vascular invasion in pancreatic cancer
por: Wakiya, Taiichi, et al.
Publicado: (2021)

Necrotizing pancreatitis complicated by retroperitoneal emphysema: two case reports
por: Chida, Kohei, et al.
Publicado: (2022)

Impact of the histological phenotype of extrahepatic bile duct carcinoma
por: Okano, Kensuke, et al.
Publicado: (2018)

Three-dimensional analysis of perineural invasion in extrahepatic cholangiocarcinoma using tissue clearing
por: Ogasawara, Hirokazu, et al.
Publicado: (2023)

Microanatomical organization of hepatic venous lymphatic system in humans
por: Umemura, Kotaro, et al.
Publicado: (2023)

CT-based deep learning enables early postoperative recurrence prediction for intrahepatic cholangiocarcinoma
por: Wakiya, Taiichi, et al.
Publicado: (2022)

Dual epigenetic changes in diabetes mellitus‐associated pancreatic ductal adenocarcinoma correlate with downregulation of E‐cadherin and worsened prognosis
por: Hara, Yutaro, et al.
Publicado: (2023)

Use of time‑density curves of dynamic contrast‑enhanced computed tomography for determination of the histological therapeutic effects of neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma
por: Goto, Shintaro, et al.
Publicado: (2023)

(18)F‑fluorodeoxyglucose positron emission tomography predicts recurrence and histological grade of extrahepatic bile duct cancer
por: Yachi, Takafumi, et al.
Publicado: (2023)

Calcifying nested stromal epithelial tumor of the liver in a patient with Klinefelter syndrome: a case report and review of the literature
por: Tsuruta, Satoru, et al.
Publicado: (2018)

Time density curve of dynamic contrast-enhanced computed tomography correlates with histological characteristics of pancreatic cancer
por: Goto, Shintaro, et al.
Publicado: (2021)

Exploration of Malignant Characteristics in Neoadjuvant Chemotherapy-Resistant Rectal Cancer, Focusing on Extramural Lesions
por: Kubota, Shunsuke, et al.
Publicado: (2023)

The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma
por: Kudo, Daisuke, et al.
Publicado: (2017)

Effective dissection for rectal cancer with lateral lymph node metastasis based on prognostic factors and recurrence type
por: Morohashi, Hajime, et al.
Publicado: (2021)

Essential Updates 2018/2019: Essential Updates for esophageal cancer surgery
por: Seto, Yasuyuki
Publicado: (2020)

Essential updates 2021/2022: Surgical outcomes of oligometastasis in pancreatic ductal adenocarcinoma
por: Yasuda, Satoshi, et al.
Publicado: (2023)

Essential updates 2019/2020: Multimodal treatment of localized pancreatic adenocarcinoma: Current topics and updates in survival outcomes and prognostic factors
por: Kato, Hiroyuki, et al.
Publicado: (2021)

Essential updates 2018/2019: Liver transplantation
por: Ohira, Masahiro, et al.
Publicado: (2020)

Diabetes in Humans Activates Pancreatic Stellate Cells via RAGE in Pancreatic Ductal Adenocarcinoma
por: Uchida, Chiaki, et al.
Publicado: (2021)

Essential updates 2018/2019: Colorectal (benign): Recent updates (2018‐2019) in the surgical treatment of benign colorectal diseases
por: Ogino, Takayuki, et al.
Publicado: (2019)

Prognostic Impact of Extracapsular Lymph Node Invasion and Myofibroblastic Activity in Extrahepatic Bile Duct Cancer
por: Yoshizawa, Tadashi, et al.
Publicado: (2017)

Diabetes mellitus impacts on expression of DNA mismatch repair protein PMS2 and tumor microenvironment in pancreatic ductal adenocarcinoma
por: Pan, Xuekai, et al.
Publicado: (2022)

Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan
por: Komatsu, Shuhei, et al.
Publicado: (2019)

Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
por: Iida‐Norita, Rie, et al.
Publicado: (2019)

Clinical features of cystatin A expression in patients with pancreatic ductal adenocarcinoma
por: Komura, Takuya, et al.
Publicado: (2017)

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting
por: Vaish, Utpreksha, et al.
Publicado: (2021)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Delay in hepatocyte proliferation and prostaglandin D2 synthase expression for cholestasis due to endotoxin during partial hepatectomy in rats
por: Wakasa, Yusuke, et al.
Publicado: (2019)

Updates on adjuvant and neoadjuvant treatment strategies for surgically resectable and borderline resectable pancreatic ductal adenocarcinoma
por: Iyengar, Siddharth, et al.
Publicado: (2021)

2018–2019 Drug Updates in Solid Tumors
por: Barbour, Sally
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6os1lh4ckdhni7g3u7gsh08uhm